Renaming the SARS-CoV-2 Omicron sublineages as SARS-CoV-3 is contrary to nomenclature standards based on evolutionary and serological evidence

Clin Transl Med. 2022 Jun;12(6):e924. doi: 10.1002/ctm2.924.

Authors

Zhongtian Qi¹, Jianbo Wu², Shibo Jiang²

Affiliations

¹ Department of Microbiology, Faculty of Naval Medicine, Naval Medical University, Shanghai, China.
² Key Laboratory of Medical Molecular Virology (MOE/NHC), Institute of Infectious Disease and Biosecurity, School of Basic Medical Sciences, Fudan University, Shanghai, China.

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Antibodies, Viral
Biological Evolution
COVID-19*
Enzyme-Linked Immunosorbent Assay
Humans
SARS-CoV-2*

Substances

Antibodies, Viral